Anis Khan

4PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 09, 2025
Pharmacokinetic-pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus.

Hongtao Yu, Victoria Parker, Viknesh Selvarajah

|Jul 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach.

Hongtao Yu, Sebastian Ueckert, Lina Zhou

|Apr 04, 2023
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.

Johanna Bendell, Patricia LoRusso, Michael Overman

|Dec 08, 2022
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma.

Xuyang Song, Robin Kate Kelley, Anis A Khan

Pageof 1

Frequent Collaborators

2 joint publications

Hongtao Yu

1 joint publications

Xuyang Song

1 joint publications

Robin Kate Kelley

1 joint publications

Nathan Standifer